Pharmafile Logo
Pharmafocus logo
Advanced Search

FDA: don’t broadcast discussion on off-label uses

January 6, 2012
Medical Communications FDA, Facebook, Twitter, off label, social media

The FDA has released long-awaited guidance for pharma firms about social media use. The FDA held a two-day public hearing …

News
lilly_entrance_web

Lilly pessimistic on 2012 performance

January 6, 2012
Sales and Marketing Eli Lilly, lilly, zyprexa

Lilly is forecasting a drop in revenue and profits for 2012, as it prepares for life without its blockbuster antipsychotic …

News
Lipitor UK video

Keep prescribing Lipitor – the generics are nearly here, says Pfizer

January 5, 2012
Medical Communications, Sales and Marketing Lipitor, NHS, Pfizer, statin prescribing

Pfizer has launched a campaign to persuade UK doctors to keep prescribing Lipitor ahead of its patent expiry in May. …

News

Biogen inks $299m deal for rare genetic disorder drug

January 5, 2012
Research and Development, Sales and Marketing Biogen, Isis Pharma

Biogen has signed a new deal with drug discovery firm Isis for its spinal muscular atrophy drug ISIS-SMNRx. Biogen will pay …

News

AstraZeneca to take Alzheimer’s drug into phase II

January 5, 2012
Research and Development Alzheimer's, AstraZeneca, Targacept

AstraZeneca is to continue the development of Targacept’s AZD1446 as a treatment for Alzheimer’s disease.AZD1446 is a selective modulator of …

News

UK to expand telehealth to three million people

January 4, 2012
Medical Communications, Sales and Marketing NHS, long term conditions, telecare, telehealth

The NHS is to expand the use of telehealth, allowing doctors to remotely monitor patients with long-term conditions.The government’s Care …

News

Orphan status for haemophilia gene therapy

January 4, 2012
Research and Development AMT, gene therapy, haemophilia

Amsterdam Molecular Therapeutics has been granted an orphan drug designation for its gene therapy for haemophilia B.The FDA’s orphan designation …

News

Missing trial data ‘threatens integrity of medicine’

January 4, 2012
Research and Development, Sales and Marketing BMJ, clincial trial data, disclosure

Missing clinical trial data can harm patients and lead to needless costs for health systems, according to new research. A …

News

Yanai steps down as Teva’s chief executive after four years at the helm

January 3, 2012
Medical Communications Teva

Shlomo Yanai is to step down as the chief executive and president of Teva, the world’s biggest generic drug makers. …

Appointment

NHS leaders say hospital use must be scaled back

January 3, 2012
Sales and Marketing

The NHS Confederation says the government must convince people to let go of the ‘outdated hospital-or-bust’ model of care. Mike …

News

GSK’s Andrew Witty knighted

January 3, 2012
Sales and Marketing Andrew Witty, GSK

GlaxoSmithKline chief executive Andrew Witty and former ABPI director general Richard Barker were among the recipients in the 2012 New …

News

Ben Venue extends plant shutdown

January 3, 2012
Manufacturing and Production Ben Venue

Troubled contract manufacturing organisation Ben Venue Laboratories has said it will have to extend its temporary shutdown of a facility …

News

Pharma manufacturing in brief

January 3, 2012
Manufacturing and Production IGI Laboratories, aseptic packaging

Pharma manufacturing news in briefCPL shuts down a facility in New Jersey, US, Tamer plans a new plant in Saudi …

News

AAIPharma expands in North Carolina

January 3, 2012
Manufacturing and Production AAIPharma

AAIPharma Services is planning to expand its contract analytics facility in Wilmington, North Carolina, with a new 40,000 sq. ft. …

News
p0024

Avastin gains EU licence for ovarian cancer

January 3, 2012
Sales and Marketing Roche, avastin, ovarian

Roche’s Avastin has been granted a new European licence to treat ovarian cancer, which could help offset falling sales of …

News

Introducing SHL’s first White Paper: “Auto Injectors: From Planning to Launch”

January 3, 2012
Manufacturing and Production auto injector, autoinjector, autoinjector manufacturing, autoinjector white paper, shl white paper

SHL is officially introducing the company’s first White Paper on the topic of “Auto Injectors; From Planning to Launch” with …

Feature
White paper

Working Life

January 1, 2012
Working Life

People working in pharma talking about what they like and dislike most about their jobs Mike Crooks, UK general manager, Astellas

Feature

Contract research news in brief

December 23, 2011
Manufacturing and Production AMRI, Frontage Labs, Kymos and Crystal3 Labs, Pacific Biomarkers/Cingene

A round up of news in the CRO sector, including cutbacks at AMRI and updates from Pacific Biomarkers/Clingene, Frontage Labs, …

News

NHS on track to make £358 million in drug savings

December 23, 2011
Sales and Marketing DoH, NHS, QIPP

The NHS in England is set to make £358 million in savings from drugs over the financial year, according to …

News
Ranbaxy picture

Ranbaxy sets aside $500m for manufacturing penalties

December 22, 2011
Manufacturing and Production

Indian drugmaker Ranbaxy Laboratories has set aside $500 million to pay financial penalties levied by the US FDA, resulting from …

News
The Gateway to Local Adoption Series

Latest content

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026